Kamis, 30 Juni 2011
Medical News Today News Alert
| Dear Subscriber, |
| Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
| Aid / Disasters News | |
| Developing Countries Witness Half Of Their Childhood Cancer Cases Not Receiving Treatment The Abandonment of Treatment Working Group of International Society of Paediatric Oncology (SIOP) has put forward recommendations to make cancer treatment available to a higher number of children in developing nations. | 30 June 2011 |
| Scaling Up Nutrition Investments Leads To Fewer Child Deaths And Improves Economy Despite improvements in the past decade, 22 per cent of all deaths among children under-five in the Kyrgyz Republic are still caused by undernutrition, according to a report launched today.Besides the loss of lives, the burden of undernutrition in the Kyrgyz Republic is also substantial in economic terms: estimated to be US$32 million annually. | 30 June 2011 |
| Three More African Countries Introduce Vaccines Against Major Childhood Killer The Governments of Central African Republic, Benin and Cameroon will introduce vaccines in the coming weeks to combat pneumonia, one of the biggest killers of children worldwide.Funded by the Global Alliance for Vaccines and Immunisation (GAVI), these life-saving vaccines prevent pneumococcal disease, the leading cause of pneumonia, which is the major cause of death among children aged below 5 years. | 30 June 2011 |
| Alcohol / Addiction / Illegal Drugs News | |
| Using 'Optogenetics' To Control Reward-Seeking Behavior Using a combination of genetic engineering and laser technology, researchers at the University of North Carolina at Chapel Hill have manipulated brain wiring responsible for reward-seeking behaviors, such as drug addiction. | 30 June 2011 |
| Just Two Talks With Teens Can Reduce Marijuana Use For At Least A Year Nearly a third of high school students in the United States report smoking marijuana. Despite the mixed messages about the safety of marijuana, smoking grass is risky behavior for teens, who are, after all, still developing. | 30 June 2011 |
| Teen Drug Use At Epidemic Levels; Smoking Is Main Gateway Almost a quarter of all youth that begin smoking, drinking or using drugs of any kind before the age of 18 go on to become severely addicted to some sort of drug in adulthood according to a new study released this week by the National Center on Addiction and Substance Abuse (CASA). | 30 June 2011 |
| Alzheimer's / Dementia News | |
| Coffee Wards Off Alzheimer's Because Unknown Ingredient Teams Up With Caffeine An unknown ingredient in coffee teams up with caffeine to stimulate blood levels of a critical protein called GCSF, short for granulocyte-colony stimulating factor, that appears to put off the development of Alzheimer's disease. | 30 June 2011 |
| Dementia Will Be The New Tax Unless A Charging Revolution Is Achieved - Alzheimer's Society, UK People do not plan for care and risk facing a 'dementia tax' unless the system of funding for care changes dramatically, Alzheimer's Society warns.Publishing the results of Dementia Tax 2011, a major investigation into charging for care for people with dementia and carers, the charity is revealing that just three per cent of people with dementia have long term care insurance. | 30 June 2011 |
| How Relevant Is Informal Care In Dementia Disorders? Rising life expectancy is associated with increasing prevalence rates of dementia disorders. In course of the disease the patients' need for care grows steadily, which imposes increasing costs of care. | 30 June 2011 |
| Anxiety / Stress News | |
| Sweating The Small Stuff: Early Adversity, Prior Depression Linked To High Sensitivity To Stress We all know people who are able to roll with life's punches, while for others, every misfortune is a jab straight to the gut. Research examining this issue has found that although most people require significant adversity to become depressed - the death of a loved one, say, or getting fired - roughly 30 percent of people with first-time depression and 60 percent of people with a history of depression develop the disorder following relatively minor misfortunes. | 30 June 2011 |
| Arthritis / Rheumatology News | |
| Zalicus Initiates Phase 2b Clinical Trial Of Synavive In Rheumatoid Arthritis Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive™, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA). | 30 June 2011 |
| Women Make More Progress Early On After Knee Replacement Surgery, Men Play Post-Op Catch-Up Although women generally have worse knee function and more severe symptoms before undergoing surgery for knee replacement than men, they recover faster after the operation. Men take longer to recover but, after a year, they catch up with women and there are no differences in surgery outcomes at that time. | 30 June 2011 |
| Autism News | |
| Asuragen And Fragile X Collaborators Report Findings Using A Novel Methylation PCR Technology To Characterize The FMR1 Gene Asuragen, Inc. announces results from an evaluation of a breakthrough PCR technology that determines the methylation status of the fragile X gene. The study was published in collaboration with researchers at the University of California Davis M. | 30 June 2011 |
| Biology / Biochemistry News | |
| IMRE Invents Synthetic Cell Membranes For Faster And Cheaper Drug Development They may look and act like natural human cell membranes but the synthetic cell membranes invented by A*STAR's IMRE have more advantages. IMRE's patented synthetic cell membranes can be made-to-order, are easier to maintain in a laboratory environment and do not require the lengthy preparation that comes with working on live cell membranes. | 30 June 2011 |
| Blocking Molecular Target Could Make More Cancers Treatable With PARP Inhibitors Researchers at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs. | 30 June 2011 |
| The Chemistry Of Instinct The mechanics of instinctive behavior are mysterious. Even something as simple as the question of how a mouse can use its powerful sense of smell to detect and evade predators, including species it has never met before, has been almost totally unknown at the molecular level until now. | 30 June 2011 |
| Variation In Susceptibility To A Virus Is The Key To Understanding Infection Biology A new study shows that differences in the vulnerability of animals to a virus are crucial to understanding patterns of infection, and that variation in susceptibility to two marginally different viruses increases the number of infections when the two virus variants are present in the same animal. | 30 June 2011 |
| Blood / Hematology News | |
| ESC Calls For Greater Awareness Of Potential For Adverse Events From Bleeding As A Result Of PCI The European Society of Cardiology (ESC) Working Group on Thrombosis is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary interventions (PCI), and for increased research in the field. | 30 June 2011 |
| Bones / Orthopedics News | |
| Medtronic Announces U.S. Launch Of New Inflatable Bone Tamp And Syringe System For Treatment Of Vertebral Compression Fractures Medtronic, Inc. (NYSE:MDT) today announced the commercial release of the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation Syringe - the Kyphon Xpander II IBT System - for the treatment of vertebral compression fractures with minimally invasive Kyphon® Balloon Kyphoplasty. | 30 June 2011 |
| Ascension Orthopedics Implants PyroTITAN™ In Geelong, Australia Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard S. | 30 June 2011 |
| Breast Cancer News | |
| Worse Outcomes For Older Breast Cancer Patients With Comorbidities A recent study led by Jennifer L. Patnaik, Ph.D., of the University of Colorado Denver, Aurora that was published in the Journal of the National Cancer Institute shows higher rates of mortality in older breast cancer patients with other health problems ('comorbidities') in contrast to patients without these problems. | 30 June 2011 |
| Triple-Negative Breast Cancer Subtypes Respond To Different Therapies Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of an aggressive and difficult-to-treat form of breast cancer, called "triple-negative breast cancer (TNBC)." In the July issue of the Journal of Clinical Investigation, Cancer Center Director Jennifer Pietenpol, Ph. | 30 June 2011 |
| Avastin Not Suitable For Breast Cancer Says FDA Panel A panel of experts that advises the US Food and Drug Administration (FDA) concluded on Wednesday that the cancer drug Avastin, generic name bevacizumab, is not a suitable treatment for breast cancer and recommended the FDA withdraw its approval of the drug for such use. | 30 June 2011 |
| Cancer / Oncology News | |
| New Study Reveals That Muscle Invasive Bladder Cancer Cells Can Become More Susceptible To Chemotherapy Sensitized muscle invasive bladder cancer cells can be eliminated by the lethal effects of chemotherapy. This has been discovered in research conducted at the UC Davis Cancer Center that was published on June 28 in the International Journal of Cancer. | 30 June 2011 |
| Developing Countries Witness Half Of Their Childhood Cancer Cases Not Receiving Treatment The Abandonment of Treatment Working Group of International Society of Paediatric Oncology (SIOP) has put forward recommendations to make cancer treatment available to a higher number of children in developing nations. | 30 June 2011 |
| Novel Analysis Method Organizes Genomic Cancer Data The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. | 30 June 2011 |
| Breakthrough Gene "Road Map" Guides Future Ovarian Cancer Research Scientists have announced this week that they've uncovered a genetic map that will help determine the future of ovarian cancer research for years to come. The largest undertaking of its kind to date has led to a better understanding of this "silent killer" and ways to treat it. | 30 June 2011 |
| Erlotinib Fails To Get An Approval Nod From NICE For Non-small Cell Lung Cancer, UK The UK's National Institute for Health and Clinical Excellence (NICE) has continued its decision of not approving erlotinib for treating locally advanced or metastatic non-small-cell lung cancer in patients who have stable disease following platinum-based chemotherapy. | 30 June 2011 |
| Worse Outcomes For Older Breast Cancer Patients With Comorbidities A recent study led by Jennifer L. Patnaik, Ph.D., of the University of Colorado Denver, Aurora that was published in the Journal of the National Cancer Institute shows higher rates of mortality in older breast cancer patients with other health problems ('comorbidities') in contrast to patients without these problems. | 30 June 2011 |
| Improving Efficacy Of Drugs For Bladder Cancer Would Boost Post-Surgery Survivorship Researchers at the UC Davis Cancer Center have discovered a way of sensitizing muscle-invasive bladder cancer cells so that they succumb to the toxic effects of chemotherapy. The finding adds to mounting evidence that tiny strands of RNA - called microRNA - play key roles in some of the deadliest types of cancer. | 30 June 2011 |
| New Therapy For Childhood Neuroblastoma Proves Feasible And Safe A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emission tomography and X-ray computed tomography (PET/CT) may be used to select children with primary refractory or relapsed high-risk neuroblastoma for treatment with a molecular radiotherapy known as 177Lu-DOTATATE. | 30 June 2011 |
| ASCO Statement On Publication Of The National Lung Screening Trial Results Following is a statement for attribution from Bruce Johnson, MD, a Board Member of the American Society of Clinical Oncology (ASCO), and lung cancer expert with the Dana-Farber Cancer Institute, on The New England Journal of Medicine's publication of the results of the National Lung Screening Trial (NLST). | 30 June 2011 |
| Avastin Not Suitable For Breast Cancer Says FDA Panel A panel of experts that advises the US Food and Drug Administration (FDA) concluded on Wednesday that the cancer drug Avastin, generic name bevacizumab, is not a suitable treatment for breast cancer and recommended the FDA withdraw its approval of the drug for such use. | 30 June 2011 |
| Is Bevacizumab Cost-Effective In Lung Cancer? An economic analysis of the drug Bevacizumab showed that this drug is not cost-effective when given with chemotherapy for advanced non-small cell lung cancer.The goal of the study was to determine if bevacizumab is cost-effective when given in combination with standard chemotherapy to patients with advanced non-small cell lung cancer. | 30 June 2011 |
| Blocking Molecular Target Could Make More Cancers Treatable With PARP Inhibitors Researchers at Dana-Farber Cancer Institute have demonstrated a molecular strategy they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs. | 30 June 2011 |
| Screening With Low-Dose Spiral CT Scanning Reduces Lung Cancer Deaths By 20 Percent Compared To Chest X-Ray Current or heavy smokers who were screened with low-dose spiral computed tomography (CT) scanning had a 20 percent reduction in deaths from lung cancer than did those who were screened by chest X-ray, according to results from a decade-long, large clinical trial that involved more than 53,000 people. | 30 June 2011 |
| Advances In Delivery Of Therapeutic Genes To Treat Brain Tumors And Other Neurological Disorders Highlighted In Human Gene Therapy Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. | 30 June 2011 |
| Project To Accelerate Targeted Cancer Therapies The Scripps Translational Science Institute (STSI) of San Diego, Calif., has joined a national consortium of research institutions headed by The Jackson Laboratory (JAX) that is building a library of primary human tumors with the goal of developing highly targeted cancer therapies. | 30 June 2011 |
| Cardiovascular / Cardiology News | |
| New NICE Quality Standard Published On Chronic Heart Failure NICE has today (30 June) published quality standards for the assessment, diagnosis and clinical management of chronic heart failure1 in adults, adding to the bank of quality standards already completed. | 30 June 2011 |
| NICE Draft Guidance Recommends New "Clot-Busting" Drug To Treat Acute Coronary Syndromes In draft guidance published today (30 June) NICE has recommended ticagrelor (Brilique, Astrazeneca) in combination with aspirin as an option to treat adults with acute coronary syndromes.Acute coronary syndromes refer to a group of heart problems ranging from myocardial infarction (heart attacks) to unstable angina, which occur due to narrowed coronary arteries. | 30 June 2011 |
| Understanding Interaction Between Hydrogen Sulphide And Nitric Oxide Could Lead To Development Of New Therapies And Interventions For Heart Failure Research carried out by scientists from the Peninsula Medical School at the University of Exeter and the National University of Singapore has analysed the complex 'cross talk' between hydrogen sulphide (H2S) and nitric oxide (NO), both gasses that occur naturally in the body, and found that the interaction may offer potential strategies in the management of heart failure. | 30 June 2011 |
| Omeros Announces Publication Of Phase 2 Clinical Results For OMS103HP In Arthroscopy Omeros Corporation (NASDAQ: OMER) reported the publication of results from a Phase 2 trial investigating OMS103HP in patients undergoing arthroscopic partial meniscectomy surgery. OMS103HP is Omeros' product candidate being developed for use during arthroscopic procedures and is designed to provide a multimodal approach to preemptively block the inflammatory cascade induced by arthroscopy. | 30 June 2011 |
| Micell Technologies Announces Reduced Clinical Trial Sample Size For MiStent® Drug-Eluting Coronary Stent Based On Early Clinical Data Micell Technologies, Inc. announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent Drug-Eluting Coronary Stent System ("MiStent DES"), an ultra-thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation. | 30 June 2011 |
| Shortening Time Between CPR And Shocks Improves Cardiac-Arrest Survival Reducing the intervals between giving cardiopulmonary resuscitation (CPR) and an electronic defibrillator shock after cardiac arrest significantly improves survival, according to UT Southwestern Medical Center emergency medicine doctors involved in an international study. | 30 June 2011 |
| ESC Calls For Greater Awareness Of Potential For Adverse Events From Bleeding As A Result Of PCI The European Society of Cardiology (ESC) Working Group on Thrombosis is calling for greater attention to be paid by health care staff to reducing bleeding in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary interventions (PCI), and for increased research in the field. | 30 June 2011 |
| Clinical Trials / Drug Trials News | |
| Zalicus Initiates Phase 2b Clinical Trial Of Synavive In Rheumatoid Arthritis Zalicus Inc. (NASDAQ: ZLCS) a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive™, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA). | 30 June 2011 |
| ASCO Statement On Publication Of The National Lung Screening Trial Results Following is a statement for attribution from Bruce Johnson, MD, a Board Member of the American Society of Clinical Oncology (ASCO), and lung cancer expert with the Dana-Farber Cancer Institute, on The New England Journal of Medicine's publication of the results of the National Lung Screening Trial (NLST). | 30 June 2011 |
| Merck Serono Initiates Phase IIIb European Study SPARK In Children Younger Than Four Years, Suffering From Phenylketonuria Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the enrollment of the first patients in SPARK1. The SPARK study will investigate the safety, efficacy and population pharmacokinetics of Kuvan® (sapropterin dihydrochloride) in patients younger than four years, who suffer from Phenylketonuria (PKU). | 30 June 2011 |
| American Lung Association Responds To Results Of National Lung Screening Trial The American Lung Association is optimistic about the promising results of the National Cancer Institute's National Lung Screening Trial, which indicate low-dose CT scans can have significant impact on lung cancer mortality. | 30 June 2011 |
| Omeros Announces Publication Of Phase 2 Clinical Results For OMS103HP In Arthroscopy Omeros Corporation (NASDAQ: OMER) reported the publication of results from a Phase 2 trial investigating OMS103HP in patients undergoing arthroscopic partial meniscectomy surgery. OMS103HP is Omeros' product candidate being developed for use during arthroscopic procedures and is designed to provide a multimodal approach to preemptively block the inflammatory cascade induced by arthroscopy. | 30 June 2011 |
| Micell Technologies Announces Reduced Clinical Trial Sample Size For MiStent® Drug-Eluting Coronary Stent Based On Early Clinical Data Micell Technologies, Inc. announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent Drug-Eluting Coronary Stent System ("MiStent DES"), an ultra-thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation. | 30 June 2011 |
| QRxPharma Releases Additional Data On Phase 3 Comparative Safety Study For MoxDuo® IR QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced the release of additional data on its Phase 3 safety study for MoxDuo IR. Study 022 compared the respiratory effects of MoxDuo IR to equi-analgesic doses of either morphine or oxycodone in 375 patients experiencing moderate to severe postoperative pain following bunionectomy surgery at 4 US clinical research sites. | 30 June 2011 |
| Complementary Medicine / Alternative Medicine News | |
| FDA: New York Dietary Supplement Manufacturer Enters Into Consent Decree The U.S. Food and Drug Administration has announced that Howard Sousa, doing business as the Artery Health Institute LLC, and DeSousa LLC, in New York, N.Y., has signed a consent decree of permanent injunction. | 30 June 2011 |
| Conferences News | |
| Biosimilars And Biobetters Conference - Next Generation Monoclonal Antibody Development And Clinical Challenges With Biosimilar Drug Development Also known as follow-on biologics, biosimilars are not like generic pharmaceuticals which can be analyzed in a laboratory to confirm that they are exact copies of chemical drugs. Biologics are vastly more complex than traditional pharmaceuticals, and producing an exact duplicate of an existing biologic is not possible with today's scienceJoin SMi at their 2nd Biosimilars and Biobetters conference where you can expect to learn about a comprehensive range of pivotal issues in this area, not just relating to the development of the US regulatory pathway and the early steps of the EMA, but also the scientific developmental agenda of major players in the fledgling industry, the unique and exciting position of mAbs in this new arena, how Biobetters and Biosuperiors could challenge second generation biologics, and analysis of global biosimilars pricings structure. | 30 June 2011 |
| Pharmacy Bodies Join Together To Represent Community Pharmacy At LGA's National Conference Pharmacy bodies have joined together to represent community pharmacy at the Local Government Association's national conference this week. Representatives from Pharmacy Voice, PSNC and the RPS are exhibiting jointly at the event, at which speakers include Prime Minister David Cameron, the Leader of the Opposition and the Health Secretary Andrew Lansley. | 30 June 2011 |
| Sydney Hosts Innovative Global Health Conference As Medical Students Learn How To Make A Difference, Australia Over 600 medical students from around Australia, New Zealand, and the Asia-Pacific region will converge on Sydney for the Australian Medical Students' Association (AMSA) seventh annual Global Health Conference from 30th June-3rd July. | 30 June 2011 |
| COPD News | |
| Regulatory Submission Of Aclidinium Bromide For The Treatment Of COPD In The USA Announced By Almirall And Forest Almirall, S.A. (ALM.MC) and Forest Laboratories, Inc. (NYSE: FRX) have announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for aclidinium bromide, a long-acting inhaled antimuscarinic agent developed for the treatment of Chronic Obstructive Pulmonary Disease (COPD). | 30 June 2011 |
| Dentistry News | |
| Gene Combination Identified As Risk Factor In Success Of Dental Implants The health of the surrounding tissue affects the success of a dental implant. Identifying and reducing risk factors is therefore a key step in the implant process. Now a combination of genes has been identified as a possible indicator of greater tissue destruction leading to negative outcomes for implants. | 30 June 2011 |
| Depression News | |
| Sweating The Small Stuff: Early Adversity, Prior Depression Linked To High Sensitivity To Stress We all know people who are able to roll with life's punches, while for others, every misfortune is a jab straight to the gut. Research examining this issue has found that although most people require significant adversity to become depressed - the death of a loved one, say, or getting fired - roughly 30 percent of people with first-time depression and 60 percent of people with a history of depression develop the disorder following relatively minor misfortunes. | 30 June 2011 |
| UK Researchers Hail First Approach To Antidepressant Medication For 20 Years Millions of people with severe, treatment-resistant depression could get their lives back by adding an anti-inflammatory drug such as aspirin to their anti-depressant medication, a leading consortium of UK researchers in biological psychiatry, the Psychiatric Research into Inflammation, Immunity and Mood Effects (PRIME), reported at the International Congress of the Royal College of Psychiatrists in Brighton. | 30 June 2011 |
| Dermatology News | |
| Indoor Tanning Tax Sends Strong Health Message: Indoor Tanning Is Unsafe The American Academy of Dermatology Association (Academy) opposes recent legislation to repeal the federal 10 percent indoor tanning tax. Countless scientific studies continue to demonstrate clear and compelling evidence that tanning bed use increases the risk of developing all forms of skin cancer. | 30 June 2011 |
| Cutting Through The Confusion About Sunscreen The July 4 weekend is a time for barbequing, lounging poolside or just goofing off in the backyard. But it's important to practice good sun safety, stress dermatologists at the University of Michigan Health System. | 30 June 2011 |
| Diabetes News | |
| American Diabetes Association Advising On The Use Of Information Technology To Improve Diabetes Prevention, Management In Beacon Communities The American Diabetes Association and the Centers for Disease Control and Prevention (CDC) are working with the Office of the National Coordinator for Health Information Technology (ONC) in an effort to inform a nationwide program to increase the use of health information technology (IT). | 30 June 2011 |
| Tiny Generator Powers Wireless Device Imagine a new genre of tiny implantable sensors, airborne and stationary surveillance cameras and sensors and other devices that operate without batteries on energy collected from the motion of a heart beat and have wireless communications capability. | 30 June 2011 |
| 3 Programs To Advance Health Research And Development The Life Sciences Discovery Fund (LSDF) has announced awards to three multi-institutional teams to support development of improved therapies and key resources for medical researchers and health-care policymakers. | 30 June 2011 |
| Eating Disorders News | |
| Scaling Up Nutrition Investments Leads To Fewer Child Deaths And Improves Economy Despite improvements in the past decade, 22 per cent of all deaths among children under-five in the Kyrgyz Republic are still caused by undernutrition, according to a report launched today.Besides the loss of lives, the burden of undernutrition in the Kyrgyz Republic is also substantial in economic terms: estimated to be US$32 million annually. | 30 June 2011 |
| Epilepsy News | |
| MAA For Perampanel, Eisai's New Drug For Treatment Of Epilepsy Accepted By European Medicines Agency For Review Eisai, a Japanese pharmaceutical company, has disclosed that its Marketing Authorization Application (MAA) for a new first-in-class epilepsy drug, perampanel, had been accepted for review by the European Medicines Agency (EMA). | 30 June 2011 |
| Variation In Make-Up Of Generic Epilepsy Drugs Can Lead To Dosing Problems Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. | 30 June 2011 |
| Fertility News | |
| Development Of Polycystic Ovary Syndrome May Be Prevented Or Delayed By Diabetes Drug A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development of polycystic ovary syndrome (PCOS) in adolescence. | 30 June 2011 |
| Flu / Cold / SARS News | |
| Infectious Disease Experts Call For Better Understanding Of How To Protect Older Americans From Influenza Americans 65 years of age and older are at the highest risk of developing severe complications from influenza, but these same individuals receive less protection from annual influenza vaccination than others. | 30 June 2011 |
| GastroIntestinal / Gastroenterology News | |
| Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET). | 30 June 2011 |
| Genetics News | |
| Novel Analysis Method Organizes Genomic Cancer Data The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. | 30 June 2011 |
| Breakthrough Gene "Road Map" Guides Future Ovarian Cancer Research Scientists have announced this week that they've uncovered a genetic map that will help determine the future of ovarian cancer research for years to come. The largest undertaking of its kind to date has led to a better understanding of this "silent killer" and ways to treat it. | 30 June 2011 |
| Asuragen And Fragile X Collaborators Report Findings Using A Novel Methylation PCR Technology To Characterize The FMR1 Gene Asuragen, Inc. announces results from an evaluation of a breakthrough PCR technology that determines the methylation status of the fragile X gene. The study was published in collaboration with researchers at the University of California Davis M. | 30 June 2011 |
| Improving Efficacy Of Drugs For Bladder Cancer Would Boost Post-Surgery Survivorship Researchers at the UC Davis Cancer Center have discovered a way of sensitizing muscle-invasive bladder cancer cells so that they succumb to the toxic effects of chemotherapy. The finding adds to mounting evidence that tiny strands of RNA - called microRNA - play key roles in some of the deadliest types of cancer. | 30 June 2011 |
| Detailed Ovarian Cancer Analysis Completed By The Cancer Genome Atlas An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature. | 30 June 2011 |
| Merck Serono Initiates Phase IIIb European Study SPARK In Children Younger Than Four Years, Suffering From Phenylketonuria Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the enrollment of the first patients in SPARK1. The SPARK study will investigate the safety, efficacy and population pharmacokinetics of Kuvan® (sapropterin dihydrochloride) in patients younger than four years, who suffer from Phenylketonuria (PKU). | 30 June 2011 |
| Evolution Of Skin And Ovarian Cancer Cells Decoded A team of researchers led by scientists at the University of California, San Francisco has developed a way to uncover the evolution of human cancer cells, determining the order in which mutations emerge in them as they wend their way from a normal, healthy state into invasive, malignant masses. | 30 June 2011 |
| Variation In Make-Up Of Generic Epilepsy Drugs Can Lead To Dosing Problems Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly if patients switch between two generic drugs, a new study by Johns Hopkins researchers suggests. | 30 June 2011 |
| The Promise Of Stem Cell-Based Gene Therapy Will Depend On Novel Gene Delivery Tools Sophisticated genetic tools and techniques for achieving targeted gene delivery and high gene expression levels in bone marrow will drive the successful application of gene therapy to treat a broad range of diseases. | 30 June 2011 |
| Advances In Delivery Of Therapeutic Genes To Treat Brain Tumors And Other Neurological Disorders Highlighted In Human Gene Therapy Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. | 30 June 2011 |
| Project To Accelerate Targeted Cancer Therapies The Scripps Translational Science Institute (STSI) of San Diego, Calif., has joined a national consortium of research institutions headed by The Jackson Laboratory (JAX) that is building a library of primary human tumors with the goal of developing highly targeted cancer therapies. | 30 June 2011 |
| Health Insurance / Medical Insurance News | |
| One-Third Of New Jersey's Immigrant Children, Nearly Three-Quarters Of Adult Newcomers Lack Health Insurance: Rutgers Study One-third of immigrant children and more than 70 percent of foreign-born, nonelderly adults living in New Jersey five years or less lack health coverage, a Rutgers statewide survey finds.The report, "Health, Coverage and Access to Care of New Jersey Immigrants," by the Rutgers Center for State Health Policy (CSHP), also concludes immigrants face significant access-to-care barriers and their lack of health insurance is a much larger problem than for New Jerseyans born in the United States. | 30 June 2011 |
| Heart Disease News | |
| New NICE Quality Standard Published On Chronic Heart Failure NICE has today (30 June) published quality standards for the assessment, diagnosis and clinical management of chronic heart failure1 in adults, adding to the bank of quality standards already completed. | 30 June 2011 |
| NICE Draft Guidance Recommends New "Clot-Busting" Drug To Treat Acute Coronary Syndromes In draft guidance published today (30 June) NICE has recommended ticagrelor (Brilique, Astrazeneca) in combination with aspirin as an option to treat adults with acute coronary syndromes.Acute coronary syndromes refer to a group of heart problems ranging from myocardial infarction (heart attacks) to unstable angina, which occur due to narrowed coronary arteries. | 30 June 2011 |
| Understanding Interaction Between Hydrogen Sulphide And Nitric Oxide Could Lead To Development Of New Therapies And Interventions For Heart Failure Research carried out by scientists from the Peninsula Medical School at the University of Exeter and the National University of Singapore has analysed the complex 'cross talk' between hydrogen sulphide (H2S) and nitric oxide (NO), both gasses that occur naturally in the body, and found that the interaction may offer potential strategies in the management of heart failure. | 30 June 2011 |
| Texas Children's Hospital Is First Pediatric Hospital In The Nation To Implant Artificial Heart Texas Children's Hospital in Houston announced that it is the first pediatric hospital in the United States to implant an artificial heart into the chest of a 17-year-old patient as the only option to save his life. | 30 June 2011 |
| Omeros Announces Publication Of Phase 2 Clinical Results For OMS103HP In Arthroscopy Omeros Corporation (NASDAQ: OMER) reported the publication of results from a Phase 2 trial investigating OMS103HP in patients undergoing arthroscopic partial meniscectomy surgery. OMS103HP is Omeros' product candidate being developed for use during arthroscopic procedures and is designed to provide a multimodal approach to preemptively block the inflammatory cascade induced by arthroscopy. | 30 June 2011 |
| Micell Technologies Announces Reduced Clinical Trial Sample Size For MiStent® Drug-Eluting Coronary Stent Based On Early Clinical Data Micell Technologies, Inc. announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent Drug-Eluting Coronary Stent System ("MiStent DES"), an ultra-thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation. | 30 June 2011 |
| Shortening Time Between CPR And Shocks Improves Cardiac-Arrest Survival Reducing the intervals between giving cardiopulmonary resuscitation (CPR) and an electronic defibrillator shock after cardiac arrest significantly improves survival, according to UT Southwestern Medical Center emergency medicine doctors involved in an international study. | 30 June 2011 |
| HIV / AIDS News | |
| UAB Youth HIV Program Earns $31.7 Million Renewal Grant The University of Alabama at Birmingham has received a five-year, $31.7 million award for its Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN), formed in 2001 to respond to the HIV epidemic in youth. | 30 June 2011 |
| Doctors To FDA: "HIV Prevention Pill" Not Ready For Approval Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP). | 30 June 2011 |
| Discovery Of HIV-Inhibiting Mechanism Highlights Link Between Innate Immune System And Viral Defense Factors Researchers at Case Western Reserve University School of Medicine have discovered a long-sought cellular factor that works to inhibit HIV infection of myeloid cells, a subset of white blood cells that display antigens and hence are important for the body's immune response against viruses and other pathogens. | 30 June 2011 |
| Hypertension News | |
| Vasomedical Receives FDA 510(k) Clearance On Two New Devices Vasomedical, Inc. ("Vasomedical") (OTC: VASO.PK), a leader in the sale of diagnostic imaging products through its wholly-owned subsidiary, VasoHealthcare, as well as a leader in the non-invasive treatment and management of cardiovascular diseases, today announced its receipt of U. | 30 June 2011 |
| Immune System / Vaccines News | |
| Three More African Countries Introduce Vaccines Against Major Childhood Killer The Governments of Central African Republic, Benin and Cameroon will introduce vaccines in the coming weeks to combat pneumonia, one of the biggest killers of children worldwide.Funded by the Global Alliance for Vaccines and Immunisation (GAVI), these life-saving vaccines prevent pneumococcal disease, the leading cause of pneumonia, which is the major cause of death among children aged below 5 years. | 30 June 2011 |
| Inovio Pharmaceuticals' DNA Vaccine For Foot-And-Mouth Disease Generates Protective Neutralizing Antibodies In Second Large-Animal Study Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved compelling immune responses in a study of its multi-subtype DNA vaccine for foot-and-mouth (FMD) disease administered by Inovio's proprietary vaccine delivery technology in sheep, the second large animal in which this vaccine was evaluated. | 30 June 2011 |
| The Fight Against Infectious Disease Aided By New Salmonella-Based 'Clean Vaccines' A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia. | 30 June 2011 |
| Discovery Of HIV-Inhibiting Mechanism Highlights Link Between Innate Immune System And Viral Defense Factors Researchers at Case Western Reserve University School of Medicine have discovered a long-sought cellular factor that works to inhibit HIV infection of myeloid cells, a subset of white blood cells that display antigens and hence are important for the body's immune response against viruses and other pathogens. | 30 June 2011 |
| Infectious Diseases / Bacteria / Viruses News | |
| Infectious Disease Experts Call For Better Understanding Of How To Protect Older Americans From Influenza Americans 65 years of age and older are at the highest risk of developing severe complications from influenza, but these same individuals receive less protection from annual influenza vaccination than others. | 30 June 2011 |
| World HAI Forum: Global Call To Action To Fight Antibiotic Resistance Over 70 international experts in medicine, infectious diseases, microbiology and epidemiology, from every continent, gathered at the Fondation Mérieux's Conference Center for the third edition of the World HAI Forum on healthcare-associated infections, a bioMérieux initiative. | 30 June 2011 |
| Three More African Countries Introduce Vaccines Against Major Childhood Killer The Governments of Central African Republic, Benin and Cameroon will introduce vaccines in the coming weeks to combat pneumonia, one of the biggest killers of children worldwide.Funded by the Global Alliance for Vaccines and Immunisation (GAVI), these life-saving vaccines prevent pneumococcal disease, the leading cause of pneumonia, which is the major cause of death among children aged below 5 years. | 30 June 2011 |
| Inovio Pharmaceuticals' DNA Vaccine For Foot-And-Mouth Disease Generates Protective Neutralizing Antibodies In Second Large-Animal Study Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved compelling immune responses in a study of its multi-subtype DNA vaccine for foot-and-mouth (FMD) disease administered by Inovio's proprietary vaccine delivery technology in sheep, the second large animal in which this vaccine was evaluated. | 30 June 2011 |
| The Fight Against Infectious Disease Aided By New Salmonella-Based 'Clean Vaccines' A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia. | 30 June 2011 |
| Urinary Tract Infections Reduced In Rehab Patients By Interdisciplinary Team Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings. | 30 June 2011 |
| Variation In Susceptibility To A Virus Is The Key To Understanding Infection Biology A new study shows that differences in the vulnerability of animals to a virus are crucial to understanding patterns of infection, and that variation in susceptibility to two marginally different viruses increases the number of infections when the two virus variants are present in the same animal. | 30 June 2011 |
| IT / Internet / E-mail News | |
| New Anti-Smoking Text Technology Doubles Quit Chances Study Says Text to stop smoking. Period. A new study has found that smokers in the United Kingdom who receive electronic text messages to their mobile devices, doubles their chances of finally kicking the habit. | 30 June 2011 |
| Artificial Sensitive Skin Developed For Robots Our skin is a communicative wonder: The nerves convey temperature, pressure, shear forces and vibrations - from the finest breath of air to touch to pain. At the same time, the skin is the organ by which we set ourselves apart from our environment and distinguish between environment and body. | 30 June 2011 |
| 3 Programs To Advance Health Research And Development The Life Sciences Discovery Fund (LSDF) has announced awards to three multi-institutional teams to support development of improved therapies and key resources for medical researchers and health-care policymakers. | 30 June 2011 |
| Litigation / Medical Malpractice News | |
| Evaluation Of Mental Health Court By SHSU Team A team of researchers at Sam Houston State University will evaluate a new mental health court in Montgomery County.The College of Criminal Justice received a grant from the Texas Task Force on Indigent Defense to evaluate the effectiveness of the new program, which will provide a managing attorney and master's-level social worker for criminal cases involving mentally ill defendants. | 30 June 2011 |
| Lung Cancer News | |
| Erlotinib Fails To Get An Approval Nod From NICE For Non-small Cell Lung Cancer, UK The UK's National Institute for Health and Clinical Excellence (NICE) has continued its decision of not approving erlotinib for treating locally advanced or metastatic non-small-cell lung cancer in patients who have stable disease following platinum-based chemotherapy. | 30 June 2011 |
| ASCO Statement On Publication Of The National Lung Screening Trial Results Following is a statement for attribution from Bruce Johnson, MD, a Board Member of the American Society of Clinical Oncology (ASCO), and lung cancer expert with the Dana-Farber Cancer Institute, on The New England Journal of Medicine's publication of the results of the National Lung Screening Trial (NLST). | 30 June 2011 |
| Is Bevacizumab Cost-Effective In Lung Cancer? An economic analysis of the drug Bevacizumab showed that this drug is not cost-effective when given with chemotherapy for advanced non-small cell lung cancer.The goal of the study was to determine if bevacizumab is cost-effective when given in combination with standard chemotherapy to patients with advanced non-small cell lung cancer. | 30 June 2011 |
| Screening With CT Scans Reduces Lung Cancer Deaths Results of the National Lung Screening Trial (NLST) published online in the June 30 New England Journal of Medicine report a twenty percent reduction in lung cancer deaths among study participants who were screened with low-dose helical computed tomography (CT) versus those screened with chest X-ray. | 30 June 2011 |
| American Lung Association Responds To Results Of National Lung Screening Trial The American Lung Association is optimistic about the promising results of the National Cancer Institute's National Lung Screening Trial, which indicate low-dose CT scans can have significant impact on lung cancer mortality. | 30 June 2011 |
| CT Scans Unleash A Breakthrough In Catching Early Stage Lung Cancer The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer. NLST data shows 20 percent fewer lung cancer deaths among trial participants who had the CT scan compared with the chest x-ray. | 30 June 2011 |
| Screening With Low-Dose Spiral CT Scanning Reduces Lung Cancer Deaths By 20 Percent Compared To Chest X-Ray Current or heavy smokers who were screened with low-dose spiral computed tomography (CT) scanning had a 20 percent reduction in deaths from lung cancer than did those who were screened by chest X-ray, according to results from a decade-long, large clinical trial that involved more than 53,000 people. | 30 June 2011 |
| UT MD Anderson Debuts Lung Cancer Screening Program Current and former heavy smokers can now be screened more effectively for lung cancer. Results from the National Lung Screening Trial (NLST) revealed that detecting small lung cancers with computed tomography (CT) reduces lung cancer specific mortality by 20 percent. | 30 June 2011 |
| Medical Devices / Diagnostics News | |
| NEC Display Solutions Receives FDA 510(k) Clearance On MD301C4 Medical Diagnostic Monitor NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync® MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians. | 30 June 2011 |
| Medtronic Announces U.S. Launch Of New Inflatable Bone Tamp And Syringe System For Treatment Of Vertebral Compression Fractures Medtronic, Inc. (NYSE:MDT) today announced the commercial release of the Kyphon Xpander II Inflatable Bone Tamp (IBT) and the Kyphon Inflation Syringe - the Kyphon Xpander II IBT System - for the treatment of vertebral compression fractures with minimally invasive Kyphon® Balloon Kyphoplasty. | 30 June 2011 |
| Vasomedical Receives FDA 510(k) Clearance On Two New Devices Vasomedical, Inc. ("Vasomedical") (OTC: VASO.PK), a leader in the sale of diagnostic imaging products through its wholly-owned subsidiary, VasoHealthcare, as well as a leader in the non-invasive treatment and management of cardiovascular diseases, today announced its receipt of U. | 30 June 2011 |
| Future Actions Predicted From Human Brain Activity Bringing the real world into the brain scanner, researchers at The University of Western Ontario from The Centre for Brain and Mind can now determine the action a person was planning, mere moments before that action is actually executed. | 30 June 2011 |
| The Robotic Hand Of The Future Researchers at Carlos III University of Madrid's (UC3M) Robotics lab are participating in the international research project known as HANDLE. The objective of the project is to create a robotic hand that can reproduce the abilities and movements of a human hand in order to achieve the optimal manipulation of objects. | 30 June 2011 |
| Tiny Generator Powers Wireless Device Imagine a new genre of tiny implantable sensors, airborne and stationary surveillance cameras and sensors and other devices that operate without batteries on energy collected from the motion of a heart beat and have wireless communications capability. | 30 June 2011 |
| Ascension Orthopedics Implants PyroTITAN™ In Geelong, Australia Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic implants, announces the implantation of the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard S. | 30 June 2011 |
| CJPS Medical Systems Launches Breakthrough Portable Vital Signs Monitor CJPS Medical Systems announced today that it is releasing this week the smallest, most featured, lowest cost, portable multi-parameter vital signs monitor on the market. In this environment of cost cutting and flexibility, and when maintaining the highest level of care is absolutely critical, the timing of the release of VitalPoint® PRO, at half the price of its closest competitors, could not be more fitting. | 30 June 2011 |
| Medical Students / Training News | |
| Sydney Hosts Innovative Global Health Conference As Medical Students Learn How To Make A Difference, Australia Over 600 medical students from around Australia, New Zealand, and the Asia-Pacific region will converge on Sydney for the Australian Medical Students' Association (AMSA) seventh annual Global Health Conference from 30th June-3rd July. | 30 June 2011 |
| Medicare / Medicaid / SCHIP News | |
| Congress Successfully Pushes CMS To Review And Rescind Burdensome Requirement Washington, D.C. - In February eighty-eight Members of the House and the Senate, led by Congressman Michael C. Burgess, M.D. (R-TX-26), Congressman Bill Pascrell Jr. (D-NJ-08), Senator Robert Menendez (D-New Jersey) and Senator Pat Roberts (R-Kansas), sent bipartisan letters to Dr. | 30 June 2011 |
| Senate Finance Committee TAA Proposal Imposes Arbitrary Cuts, Will Restrict Patient Access, AMIC Says The Access to Medical Imaging Coalition (AMIC) said today the Senate Finance Committee proposal to drastically reduce Medicare payments for critical screening and diagnostic imaging services will further harm patient access to care in their communities, causing delays in diagnosis and treatment of life-threatening illnesses, including heart disease and cancers. | 30 June 2011 |
| Melanoma / Skin Cancer News | |
| Indoor Tanning Tax Sends Strong Health Message: Indoor Tanning Is Unsafe The American Academy of Dermatology Association (Academy) opposes recent legislation to repeal the federal 10 percent indoor tanning tax. Countless scientific studies continue to demonstrate clear and compelling evidence that tanning bed use increases the risk of developing all forms of skin cancer. | 30 June 2011 |
| Cutting Through The Confusion About Sunscreen The July 4 weekend is a time for barbequing, lounging poolside or just goofing off in the backyard. But it's important to practice good sun safety, stress dermatologists at the University of Michigan Health System. | 30 June 2011 |
| Heart Transplant Patients At Risk For Serious Skin Cancers A new study published in the American Journal of Transplantation reveals that there is a significant risk of serious skin cancers, including cutaneous squamous cell carcinoma and melanoma, in heart transplant patients. | 30 June 2011 |
| Evolution Of Skin And Ovarian Cancer Cells Decoded A team of researchers led by scientists at the University of California, San Francisco has developed a way to uncover the evolution of human cancer cells, determining the order in which mutations emerge in them as they wend their way from a normal, healthy state into invasive, malignant masses. | 30 June 2011 |
| Mental Health News | |
| "Disturbed" Jared Loughner Will Be Forced Anti-Psychotics In Prison Jared Lee Loughner will be forced anti-psychotic drugs. U.S. District Judge Larry Burns, at a hearing in San Diego, denied a request by Loughner's lawyer to prevent prison doctors from given him anti-psychotic drugs against his will. | 30 June 2011 |
| Saving Veterans From Suicide An estimated 18 American military veterans take their own lives every day - thousands each year - and those numbers are steadily increasing. Even after weathering the stresses of military life and the terrors of combat, these soldiers find themselves overwhelmed by the transition back into civilian life. | 30 June 2011 |
| UK Researchers Hail First Approach To Antidepressant Medication For 20 Years Millions of people with severe, treatment-resistant depression could get their lives back by adding an anti-inflammatory drug such as aspirin to their anti-depressant medication, a leading consortium of UK researchers in biological psychiatry, the Psychiatric Research into Inflammation, Immunity and Mood Effects (PRIME), reported at the International Congress of the Royal College of Psychiatrists in Brighton. | 30 June 2011 |
| NAMI Manual For Police, School CIT To Help Children And Teens; 70 Percent Of Youth In Juvenile Justice System Have Mental Illness The National Alliance on Mental Illness (NAMI) has published a crisis intervention team (CIT) manual for families, police, schools, mental health professionals and others to build local programs to help youth with mental illness. | 30 June 2011 |
| Evaluation Of Mental Health Court By SHSU Team A team of researchers at Sam Houston State University will evaluate a new mental health court in Montgomery County.The College of Criminal Justice received a grant from the Texas Task Force on Indigent Defense to evaluate the effectiveness of the new program, which will provide a managing attorney and master's-level social worker for criminal cases involving mentally ill defendants. | 30 June 2011 |
| MRI / PET / Ultrasound News | |
| ZONARE Scores In Clinical Applications, Performance And Customer Support & Service In KLAS 2011 Ultrasound Report ZONARE Medical Systems, a global developer of high-end ultrasound systems, announced it ranked highest in performance across a number of clinical applications and ranked first or second in several customer support and service categories in the KLAS "Ultrasound 2011: Innovation on the Move" report. | 30 June 2011 |
| CT Scans Unleash A Breakthrough In Catching Early Stage Lung Cancer The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer. NLST data shows 20 percent fewer lung cancer deaths among trial participants who had the CT scan compared with the chest x-ray. | 30 June 2011 |
| Screening With Low-Dose Spiral CT Scanning Reduces Lung Cancer Deaths By 20 Percent Compared To Chest X-Ray Current or heavy smokers who were screened with low-dose spiral computed tomography (CT) scanning had a 20 percent reduction in deaths from lung cancer than did those who were screened by chest X-ray, according to results from a decade-long, large clinical trial that involved more than 53,000 people. | 30 June 2011 |
| MRSA / Drug Resistance News | |
| World HAI Forum: Global Call To Action To Fight Antibiotic Resistance Over 70 international experts in medicine, infectious diseases, microbiology and epidemiology, from every continent, gathered at the Fondation Mérieux's Conference Center for the third edition of the World HAI Forum on healthcare-associated infections, a bioMérieux initiative. | 30 June 2011 |
| Multiple Sclerosis News | |
| Statement By Minister Aglukkaq On Chronic Cerebrospinal Venous Insufficiency And Multiple Sclerosis, Canada The Honourable Leona Aglukkaq, Minister of Health, today issued the following statement:This morning I was briefed by Dr. Alain Beaudet, President of the Canadian Institutes of Health Research (CIHR), who chaired a meeting yesterday with the Scientific Expert Working Group on Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS). | 30 June 2011 |
| Neurology / Neuroscience News | |
| Coffee Wards Off Alzheimer's Because Unknown Ingredient Teams Up With Caffeine An unknown ingredient in coffee teams up with caffeine to stimulate blood levels of a critical protein called GCSF, short for granulocyte-colony stimulating factor, that appears to put off the development of Alzheimer's disease. | 30 June 2011 |
| Eat Today, Pay Tomorrow - Lean Women Think Ahead Study reveals possible gender-specific influence of overeating on the brain.Being overweight is accompanied by changes in brain structure and behaviour. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences and the Integrated Research and Treatment Center Adiposity Diseases in Leipzig have shown that there are also differences between men and women. | 30 June 2011 |
| A Role For Glia In The Progression Of Rett Syndrome A paper published online in Nature reveals that glia play a key role in preventing the progression of the most prominent Rett Syndrome symptoms displayed by mouse models of the disease: lethality, irregular breathing and apneas, hypoactivity and decreased dendritic complexity. | 30 June 2011 |
| Future Actions Predicted From Human Brain Activity Bringing the real world into the brain scanner, researchers at The University of Western Ontario from The Centre for Brain and Mind can now determine the action a person was planning, mere moments before that action is actually executed. | 30 June 2011 |
| New Therapy For Childhood Neuroblastoma Proves Feasible And Safe A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emission tomography and X-ray computed tomography (PET/CT) may be used to select children with primary refractory or relapsed high-risk neuroblastoma for treatment with a molecular radiotherapy known as 177Lu-DOTATATE. | 30 June 2011 |
| Using 'Optogenetics' To Control Reward-Seeking Behavior Using a combination of genetic engineering and laser technology, researchers at the University of North Carolina at Chapel Hill have manipulated brain wiring responsible for reward-seeking behaviors, such as drug addiction. | 30 June 2011 |
| Merck Serono Initiates Phase IIIb European Study SPARK In Children Younger Than Four Years, Suffering From Phenylketonuria Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the enrollment of the first patients in SPARK1. The SPARK study will investigate the safety, efficacy and population pharmacokinetics of Kuvan® (sapropterin dihydrochloride) in patients younger than four years, who suffer from Phenylketonuria (PKU). | 30 June 2011 |
| Statement By Minister Aglukkaq On Chronic Cerebrospinal Venous Insufficiency And Multiple Sclerosis, Canada The Honourable Leona Aglukkaq, Minister of Health, today issued the following statement:This morning I was briefed by Dr. Alain Beaudet, President of the Canadian Institutes of Health Research (CIHR), who chaired a meeting yesterday with the Scientific Expert Working Group on Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS). | 30 June 2011 |
| Advances In Delivery Of Therapeutic Genes To Treat Brain Tumors And Other Neurological Disorders Highlighted In Human Gene Therapy Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. | 30 June 2011 |
| Stem Cell Breakthrough Shows Multi Regen Of Nervous System Neurons Stem cell research seems like it is not going anywhere fast. In fact breakthroughs are being announced more and more frequently. This week a Johns Hopkins team has discovered in young adult mice that a lone brain stem cell is capable not only of replacing itself and generating specialized neurons and glia (important types of brain cells), but also of taking a wholly unexpected path: generating two new brain stem cells. | 30 June 2011 |
| The Chemistry Of Instinct The mechanics of instinctive behavior are mysterious. Even something as simple as the question of how a mouse can use its powerful sense of smell to detect and evade predators, including species it has never met before, has been almost totally unknown at the molecular level until now. | 30 June 2011 |
| Nursing / Midwifery News | |
| Navy Nurse Protects Military Personnel From Disease Threats Around The World When U.S. Navy and other military service personnel at Naval Station Great Lakes in Illinois are deployed overseas, they can thank Immunization Nurse Specialist Stephen W. Dolak, BSN, BSEd, RN, for protecting them against vaccine-preventable diseases that are prevalent worldwide or endemic to certain lands. | 30 June 2011 |
| Nutrition / Diet News | |
| Coffee Wards Off Alzheimer's Because Unknown Ingredient Teams Up With Caffeine An unknown ingredient in coffee teams up with caffeine to stimulate blood levels of a critical protein called GCSF, short for granulocyte-colony stimulating factor, that appears to put off the development of Alzheimer's disease. | 30 June 2011 |
| Early Child Nutrition May Be Linked To Long-Term Health Outcomes In At-Risk Populations And Picky Eaters Results from studies presented by Pfizer Nutrition at the 5th Europaediatrics Congress in Vienna provide further evidence that appropriate feeding practices are critical to support the healthy growth and development of at-risk infants and picky eaters facing nutritional challenges. | 30 June 2011 |
| Intravenous Nutrition For Critically Ill Patients Must Not Be Administered Too Early Intravenous nutrition does not have a positive effect on the recovery of critically ill patients if it is administered early. Recovery from critical illness is in fact faster when patients receive supplementary intravenous nutrition one week after their admission to intensive care. | 30 June 2011 |
| Obesity / Weight Loss / Fitness News | |
| Eat Today, Pay Tomorrow - Lean Women Think Ahead Study reveals possible gender-specific influence of overeating on the brain.Being overweight is accompanied by changes in brain structure and behaviour. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences and the Integrated Research and Treatment Center Adiposity Diseases in Leipzig have shown that there are also differences between men and women. | 30 June 2011 |
| Ovarian Cancer News | |
| Breakthrough Gene "Road Map" Guides Future Ovarian Cancer Research Scientists have announced this week that they've uncovered a genetic map that will help determine the future of ovarian cancer research for years to come. The largest undertaking of its kind to date has led to a better understanding of this "silent killer" and ways to treat it. | 30 June 2011 |
| Detailed Ovarian Cancer Analysis Completed By The Cancer Genome Atlas An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature. | 30 June 2011 |
| Evolution Of Skin And Ovarian Cancer Cells Decoded A team of researchers led by scientists at the University of California, San Francisco has developed a way to uncover the evolution of human cancer cells, determining the order in which mutations emerge in them as they wend their way from a normal, healthy state into invasive, malignant masses. | 30 June 2011 |
| Pain / Anesthetics News | |
| Boston Scientific Welcomes Publication Of Landmark Report On Chronic Pain Boston Scientific Corporation (NYSE: BSX) welcomes the recent landmark report to Congress by the Institute of Medicine (IOM) of the National Academy of Sciences titled Relieving Pain in America: A Blueprint for Transforming Prevention, Treatment, and Research. | 30 June 2011 |
| IOM Report Calls For Cultural Transformation Of Attitudes Toward Pain And Its Prevention And Management Every year, at least 116 million adult Americans experience chronic pain, a condition that costs the nation between $560 billion and $635 billion annually, says a new report from the Institute of Medicine. | 30 June 2011 |
| Medtronic Commends Congress And The Institute Of Medicine On Study On Advancing Pain Research, Care And Education Medtronic, Inc. (NYSE: MDT) today commended the U.S. Congress and the Institute of Medicine (IOM) of the National Academy of Sciences on the release of Relieving Pain in America: A Blueprint for Transforming Prevention, Treatment and Research, a comprehensive study exploring the issue of pain management in the U. | 30 June 2011 |
| Consumers, Health Professionals And Advocates Hail Release Of Landmark Institute Of Medicine Report On Relieving Pain In America A broad group of consumers, health professionals and advocates today - including members of the Campaign to End Chronic Pain in Women - joined to release a statement praising the Institute of Medicine's Relieving Pain in America: Blueprint for Transforming Prevention, Treatment and Research, tackling a major health problem that impacts 116 million Americans and costs over $500 billion a year. | 30 June 2011 |
| The American Academy Of Pain Medicine Applauds IOM Findings Calling For Major Changes In Pain Research, Care, Education And Treatment For the one of every four American adults who suffers from chronic pain, the findings released today by the Institute of Medicine in its report, "Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research" will evoke a sigh of relief. | 30 June 2011 |
| QRxPharma Releases Additional Data On Phase 3 Comparative Safety Study For MoxDuo® IR QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced the release of additional data on its Phase 3 safety study for MoxDuo IR. Study 022 compared the respiratory effects of MoxDuo IR to equi-analgesic doses of either morphine or oxycodone in 375 patients experiencing moderate to severe postoperative pain following bunionectomy surgery at 4 US clinical research sites. | 30 June 2011 |
| 116 Million Americans Suffer Chronic Pain, Huge Personal And Economic Burden Not only does chronic pain affect the quality of life of over 116 million Americans, there is a massive economic burden too, estimated to be between $560 and $635 billion each year for the country, researchers from the Committee on Advancing Pain Research, Care, and Education; IOM (Institute of Medicine) revealed in a report issued today. | 30 June 2011 |
| Pancreatic Cancer News | |
| Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET). | 30 June 2011 |
| Parkinson's Disease News | |
| New Algorithm Reveals Twice As Many Sufferers Of Parkinson's As Previously Estimated Parkinson's Disease, brought to public awareness by figures such as Michael J. Fox, is not just difficult to diagnose. It's also difficult to accurately estimate how many people actually suffer from the disease. | 30 June 2011 |
| Pediatrics / Children's Health News | |
| Developing Countries Witness Half Of Their Childhood Cancer Cases Not Receiving Treatment The Abandonment of Treatment Working Group of International Society of Paediatric Oncology (SIOP) has put forward recommendations to make cancer treatment available to a higher number of children in developing nations. | 30 June 2011 |
| Early Child Nutrition May Be Linked To Long-Term Health Outcomes In At-Risk Populations And Picky Eaters Results from studies presented by Pfizer Nutrition at the 5th Europaediatrics Congress in Vienna provide further evidence that appropriate feeding practices are critical to support the healthy growth and development of at-risk infants and picky eaters facing nutritional challenges. | 30 June 2011 |
| MIT: Trade-Off Between Direct Instruction And Independent Exploration In Learning Discovered Suppose someone showed you a novel gadget and told you, "Here's how it works," while demonstrating a single function, such as pushing a button. What would you do when they handed it to you?You'd probably push the button. | 30 June 2011 |
| Development Of Polycystic Ovary Syndrome May Be Prevented Or Delayed By Diabetes Drug A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development of polycystic ovary syndrome (PCOS) in adolescence. | 30 June 2011 |
| A Role For Glia In The Progression Of Rett Syndrome A paper published online in Nature reveals that glia play a key role in preventing the progression of the most prominent Rett Syndrome symptoms displayed by mouse models of the disease: lethality, irregular breathing and apneas, hypoactivity and decreased dendritic complexity. | 30 June 2011 |
| Reaching Girls Before They Become Sexually Active: An International Model For Promoting Female Health In Africa The onset of puberty is a critical moment for reaching girls with health messages and information, and the stakes are particularly high in countries where the HIV/AIDS epidemic rages and where threats to female reproductive health abound. | 30 June 2011 |
| New Therapy For Childhood Neuroblastoma Proves Feasible And Safe A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine. The study tested the principle that combined positron emission tomography and X-ray computed tomography (PET/CT) may be used to select children with primary refractory or relapsed high-risk neuroblastoma for treatment with a molecular radiotherapy known as 177Lu-DOTATATE. | 30 June 2011 |
| One-Third Of New Jersey's Immigrant Children, Nearly Three-Quarters Of Adult Newcomers Lack Health Insurance: Rutgers Study One-third of immigrant children and more than 70 percent of foreign-born, nonelderly adults living in New Jersey five years or less lack health coverage, a Rutgers statewide survey finds.The report, "Health, Coverage and Access to Care of New Jersey Immigrants," by the Rutgers Center for State Health Policy (CSHP), also concludes immigrants face significant access-to-care barriers and their lack of health insurance is a much larger problem than for New Jerseyans born in the United States. | 30 June 2011 |
| NAMI Manual For Police, School CIT To Help Children And Teens; 70 Percent Of Youth In Juvenile Justice System Have Mental Illness The National Alliance on Mental Illness (NAMI) has published a crisis intervention team (CIT) manual for families, police, schools, mental health professionals and others to build local programs to help youth with mental illness. | 30 June 2011 |
| 7 Out Of 10 Children Do Not Wear Sunglasses Outdoors Even with new regulations on the labeling of sunscreen products to help consumers better protect their skin, many Americans are still unaware of the sun's damaging effects on their eyes. In fact, a survey by VSP® Vision Care found that while 68 percent of adults wear sunglasses outdoors, less than 30 percent of children wear sunglasses outdoors. | 30 June 2011 |
| Texas Children's Hospital Is First Pediatric Hospital In The Nation To Implant Artificial Heart Texas Children's Hospital in Houston announced that it is the first pediatric hospital in the United States to implant an artificial heart into the chest of a 17-year-old patient as the only option to save his life. | 30 June 2011 |
| Pharma Industry / Biotech Industry News | |
| MAA For Perampanel, Eisai's New Drug For Treatment Of Epilepsy Accepted By European Medicines Agency For Review Eisai, a Japanese pharmaceutical company, has disclosed that its Marketing Authorization Application (MAA) for a new first-in-class epilepsy drug, perampanel, had been accepted for review by the European Medicines Agency (EMA). | 30 June 2011 |
| Biosimilars And Biobetters Conference - Next Generation Monoclonal Antibody Development And Clinical Challenges With Biosimilar Drug Development Also known as follow-on biologics, biosimilars are not like generic pharmaceuticals which can be analyzed in a laboratory to confirm that they are exact copies of chemical drugs. Biologics are vastly more complex than traditional pharmaceuticals, and producing an exact duplicate of an existing biologic is not possible with today's scienceJoin SMi at their 2nd Biosimilars and Biobetters conference where you can expect to learn about a comprehensive range of pivotal issues in this area, not just relating to the development of the US regulatory pathway and the early steps of the EMA, but also the scientific developmental agenda of major players in the fledgling industry, the unique and exciting position of mAbs in this new arena, how Biobetters and Biosuperiors could challenge second generation biologics, and analysis of global biosimilars pricings structure. | 30 June 2011 |
| QRxPharma Releases Additional Data On Phase 3 Comparative Safety Study For MoxDuo® IR QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced the release of additional data on its Phase 3 safety study for MoxDuo IR. Study 022 compared the respiratory effects of MoxDuo IR to equi-analgesic doses of either morphine or oxycodone in 375 patients experiencing moderate to severe postoperative pain following bunionectomy surgery at 4 US clinical research sites. | 30 June 2011 |
| Pharmacy / Pharmacist News | |
| Pharmacy Bodies Join Together To Represent Community Pharmacy At LGA's National Conference Pharmacy bodies have joined together to represent community pharmacy at the Local Government Association's national conference this week. Representatives from Pharmacy Voice, PSNC and the RPS are exhibiting jointly at the event, at which speakers include Prime Minister David Cameron, the Leader of the Opposition and the Health Secretary Andrew Lansley. | 30 June 2011 |
| Preventive Medicine News | |
| Doctors To FDA: "HIV Prevention Pill" Not Ready For Approval Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP). | 30 June 2011 |
| The American Academy Of Pain Medicine Applauds IOM Findings Calling For Major Changes In Pain Research, Care, Education And Treatment For the one of every four American adults who suffers from chronic pain, the findings released today by the Institute of Medicine in its report, "Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research" will evoke a sigh of relief. | 30 June 2011 |
| Primary Care / General Practice News | |
| BMA Calls For Talks With Government As Doctors Attack Myth Of "Gold-Plated" Pensions, UK The BMA today repeated its call for talks with the government on pensions, as new figures show that many junior doctors could be better off investing in a private pension than joining the reformed NHS scheme. | 30 June 2011 |
| GP Reward Scheme May Lead To "Unintended Consequences", Reveals A New Study, UK A study published on bmj.com today states that while the GP performance scheme in the UK has led to improvement in the quality of care; there have been small deleterious consequences on aspects of care that are non-incentivized. | 30 June 2011 |
| Video Consultation Initiative Great Opportunity For Patients And GPs, Australia With the new video consultation MBS items being available from 1 July 2011, the Royal Australian College of General Practitioners (RACGP) is committed to supporting the profession during the telehealth rollout and highlights the value of the GP in this healthcare model. | 30 June 2011 |
| Psychology / Psychiatry News | |
| Sweating The Small Stuff: Early Adversity, Prior Depression Linked To High Sensitivity To Stress We all know people who are able to roll with life's punches, while for others, every misfortune is a jab straight to the gut. Research examining this issue has found that although most people require significant adversity to become depressed - the death of a loved one, say, or getting fired - roughly 30 percent of people with first-time depression and 60 percent of people with a history of depression develop the disorder following relatively minor misfortunes. | 30 June 2011 |
| MIT: Trade-Off Between Direct Instruction And Independent Exploration In Learning Discovered Suppose someone showed you a novel gadget and told you, "Here's how it works," while demonstrating a single function, such as pushing a button. What would you do when they handed it to you?You'd probably push the button. | 30 June 2011 |
| "Disturbed" Jared Loughner Will Be Forced Anti-Psychotics In Prison Jared Lee Loughner will be forced anti-psychotic drugs. U.S. District Judge Larry Burns, at a hearing in San Diego, denied a request by Loughner's lawyer to prevent prison doctors from given him anti-psychotic drugs against his will. | 30 June 2011 |
| Researchers Look Around The World For Ingredients Of Happiness In 1943, American psychologist Abraham Maslow proposed that all humans seek to fulfill a hierarchy of needs, which he represented with a pyramid. The pyramid's base, which he believed must come first, signified basic needs (for food, sleep and sex, for example). | 30 June 2011 |
| Saving Veterans From Suicide An estimated 18 American military veterans take their own lives every day - thousands each year - and those numbers are steadily increasing. Even after weathering the stresses of military life and the terrors of combat, these soldiers find themselves overwhelmed by the transition back into civilian life. | 30 June 2011 |
| Future Actions Predicted From Human Brain Activity Bringing the real world into the brain scanner, researchers at The University of Western Ontario from The Centre for Brain and Mind can now determine the action a person was planning, mere moments before that action is actually executed. | 30 June 2011 |
| UK Researchers Hail First Approach To Antidepressant Medication For 20 Years Millions of people with severe, treatment-resistant depression could get their lives back by adding an anti-inflammatory drug such as aspirin to their anti-depressant medication, a leading consortium of UK researchers in biological psychiatry, the Psychiatric Research into Inflammation, Immunity and Mood Effects (PRIME), reported at the International Congress of the Royal College of Psychiatrists in Brighton. | 30 June 2011 |
| Using 'Optogenetics' To Control Reward-Seeking Behavior Using a combination of genetic engineering and laser technology, researchers at the University of North Carolina at Chapel Hill have manipulated brain wiring responsible for reward-seeking behaviors, such as drug addiction. | 30 June 2011 |
| NAMI Manual For Police, School CIT To Help Children And Teens; 70 Percent Of Youth In Juvenile Justice System Have Mental Illness The National Alliance on Mental Illness (NAMI) has published a crisis intervention team (CIT) manual for families, police, schools, mental health professionals and others to build local programs to help youth with mental illness. | 30 June 2011 |
| The Chemistry Of Instinct The mechanics of instinctive behavior are mysterious. Even something as simple as the question of how a mouse can use its powerful sense of smell to detect and evade predators, including species it has never met before, has been almost totally unknown at the molecular level until now. | 30 June 2011 |
| Public Health News | |
| Firework Precautions To Help Keep Your Family Safe This Summer Fireworks can result in severe burns, scars and disfigurement that can last a lifetime. Fireworks that are often thought to be safe, such as sparklers, can reach temperatures above 2000 degrees Fahrenheit, and can burn users and bystanders. | 30 June 2011 |
| Tylenol Recall Again; Shipping Treatment Chemical To Blame Says J&J Johnson & Johnson (J&J)said it is recalling more than 60,000 bottles of Tylenol Extra Strength caplets because of a musty odor that has led the company to withdraw dozens of other products since last year. | 30 June 2011 |
| Dust On Office Surfaces Can Be A Source Of Exposure To PBDEs In a study of 31 Boston offices, polybrominated diphenyl ether (PBDE) flame retardants now banned internationally by the Stockholm Convention on Persistent Organic Pollutants were detected in every office tested. | 30 June 2011 |
| New Ad Campaign Urges Patients To Consider Medical Treatment Options "Explore Your Treatment Options," a new multimedia ad campaign announced today by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality and the Ad Council, encourages patients to become more informed about their options before choosing a treatment for a health condition or illness. | 30 June 2011 |
| Global Health R&D Is Central To Jobs, Income In Georgia Nearly three-quarters (74%) of Georgia residents think spending money on research to improve health globally is important for economic development in Georgia, according to a new statewide poll commissioned by Research!America. | 30 June 2011 |
| Taking Your Pet Abroad: New Rules To Come Into Force In 2012 Defra has announced that new rules on pet travel will be introduced from 1st January 2012. The changes will mean that the rules on rabies vaccination for entry into the UK will be in line with the rest of Europe. | 30 June 2011 |
| Alliance Calls On Government To Ensure Clinical Commissioning Groups' Independence Following giving evidence at Health and Social Care Bill Committee, the NHS Alliance has called on the government to ensure that clinical commissioning groups are not over constrained or straight jacketed "We have concerns about centralisation, which is implicit in the government's response to the form clinical commissioning groups will take," said Dr Michael Dixon, NHS Alliance chairman. | 30 June 2011 |
| Can Quality Of Life Be Used To Predict Health Preferences? Researchers at the University of Texas MD Anderson Cancer Center in Houston, TX (US) have developed a utility mapping algorithm from quality of life measures to facilitate cost-benefit analyses when no direct measures of patient health preferences are available. | 30 June 2011 |
| Modelling Correlated Outcomes In Health Technology Appraisals Many clinical treatments have multiple effects that can only be effectively captured on multiple outcome scales. Correctly modeling the inter-relationships between outcome scales is an important - but often ignored - component of a robust cost-effectiveness analysis and will influence whether a health care treatment is considered cost-effective. | 30 June 2011 |
| The American Academy Of Pain Medicine Applauds IOM Findings Calling For Major Changes In Pain Research, Care, Education And Treatment For the one of every four American adults who suffers from chronic pain, the findings released today by the Institute of Medicine in its report, "Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research" will evoke a sigh of relief. | 30 June 2011 |
| Plans To Replace Most Polluting Trucks In The Mid-Atlantic States Four Mid-Atlantic States are teaming up to offer one of the nation's most generous programs aimed at replacing old, highly polluting trucks.Led by the University of Maryland and the Mid-Atlantic Regional Air Management Association (MARAMA), the new program will target the so-called short-haul "drayage" fleet that shuttles between their major ports, warehouses and local stores. | 30 June 2011 |
| Radiology / Nuclear Medicine News | |
| Screening With CT Scans Reduces Lung Cancer Deaths Results of the National Lung Screening Trial (NLST) published online in the June 30 New England Journal of Medicine report a twenty percent reduction in lung cancer deaths among study participants who were screened with low-dose helical computed tomography (CT) versus those screened with chest X-ray. | 30 June 2011 |
| Regulatory Affairs / Drug Approvals News | |
| FDA: New York Dietary Supplement Manufacturer Enters Into Consent Decree The U.S. Food and Drug Administration has announced that Howard Sousa, doing business as the Artery Health Institute LLC, and DeSousa LLC, in New York, N.Y., has signed a consent decree of permanent injunction. | 30 June 2011 |
| Tylenol Recall Again; Shipping Treatment Chemical To Blame Says J&J Johnson & Johnson (J&J)said it is recalling more than 60,000 bottles of Tylenol Extra Strength caplets because of a musty odor that has led the company to withdraw dozens of other products since last year. | 30 June 2011 |
| NEC Display Solutions Receives FDA 510(k) Clearance On MD301C4 Medical Diagnostic Monitor NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 30-inch MultiSync® MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians. | 30 June 2011 |
| Vasomedical Receives FDA 510(k) Clearance On Two New Devices Vasomedical, Inc. ("Vasomedical") (OTC: VASO.PK), a leader in the sale of diagnostic imaging products through its wholly-owned subsidiary, VasoHealthcare, as well as a leader in the non-invasive treatment and management of cardiovascular diseases, today announced its receipt of U. | 30 June 2011 |
| Doctors To FDA: "HIV Prevention Pill" Not Ready For Approval Last week, a group of 55 U.S. physicians sent a letter to the U.S. Food & Drug Administration (FDA), urging the agency not to approve the use of Gilead's HIV/AIDS treatment drug Truvada for use as an HIV prevention pill - also known as "pre-exposure prophylaxis" (PrEP). | 30 June 2011 |
| Regulatory Submission Of Aclidinium Bromide For The Treatment Of COPD In The USA Announced By Almirall And Forest Almirall, S.A. (ALM.MC) and Forest Laboratories, Inc. (NYSE: FRX) have announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for aclidinium bromide, a long-acting inhaled antimuscarinic agent developed for the treatment of Chronic Obstructive Pulmonary Disease (COPD). | 30 June 2011 |
| Avastin Not Suitable For Breast Cancer Says FDA Panel A panel of experts that advises the US Food and Drug Administration (FDA) concluded on Wednesday that the cancer drug Avastin, generic name bevacizumab, is not a suitable treatment for breast cancer and recommended the FDA withdraw its approval of the drug for such use. | 30 June 2011 |
| Rehabilitation / Physical Therapy News | |
| The Robotic Hand Of The Future Researchers at Carlos III University of Madrid's (UC3M) Robotics lab are participating in the international research project known as HANDLE. The objective of the project is to create a robotic hand that can reproduce the abilities and movements of a human hand in order to achieve the optimal manipulation of objects. | 30 June 2011 |
| Urinary Tract Infections Reduced In Rehab Patients By Interdisciplinary Team Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings. | 30 June 2011 |
| Respiratory / Asthma News | |
| A Novel Airway Stem Cell Discovered By Scientists At The Broad Stem Cell Research Center At UCLA A new type of pulmonary stem cell has been identified by scientists at UCLA. These cells have a potential to regenerate large damaged airways and play an important role in strengthening immunity against infectious agents and environmental toxins. | 30 June 2011 |
| Black Children More Likely To Be Hospitalized For Severe Asthma Attacks Black children were four times more likely than white children to be hospitalized for a severe asthma attack in 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. | 30 June 2011 |
| Erlotinib Fails To Get An Approval Nod From NICE For Non-small Cell Lung Cancer, UK The UK's National Institute for Health and Clinical Excellence (NICE) has continued its decision of not approving erlotinib for treating locally advanced or metastatic non-small-cell lung cancer in patients who have stable disease following platinum-based chemotherapy. | 30 June 2011 |
| American Lung Association Responds To Results Of National Lung Screening Trial The American Lung Association is optimistic about the promising results of the National Cancer Institute's National Lung Screening Trial, which indicate low-dose CT scans can have significant impact on lung cancer mortality. | 30 June 2011 |
| Delayed Recognition Of Tuberous Sclerosis Complex In Adult Women Has Life-Threatening Consequences Women with tuberous sclerosis complex (TSC) are often misdiagnosed because the condition, commonly recognized in early childhood when it presents with seizures, manifests differently later in life, typically with renal angiomyolipomas a benign tumor of the kidney and pulmonary lymphangioleiomyomatosis (LAM) a rare lung disease that affects almost exclusively women. | 30 June 2011 |
| Schizophrenia News | |
| Evaluation Of Mental Health Court By SHSU Team A team of researchers at Sam Houston State University will evaluate a new mental health court in Montgomery County.The College of Criminal Justice received a grant from the Texas Task Force on Indigent Defense to evaluate the effectiveness of the new program, which will provide a managing attorney and master's-level social worker for criminal cases involving mentally ill defendants. | 30 June 2011 |
| Seniors / Aging News | |
| Infectious Disease Experts Call For Better Understanding Of How To Protect Older Americans From Influenza Americans 65 years of age and older are at the highest risk of developing severe complications from influenza, but these same individuals receive less protection from annual influenza vaccination than others. | 30 June 2011 |
| The Stroke Association Comments On British Geriatric Society Report, UK Healthcare support to 400,000 older people in care homes needs significant improvement says new BGS inquiry.Today, a new report, Quest for Quality by the British Geriatrics Society (BGS), highlighted many vulnerable older people resident in care homes are frequently denied access to routine NHS healthcare because they live in care homes. | 30 June 2011 |
| Sexual Health / STDs News | |
| Reaching Girls Before They Become Sexually Active: An International Model For Promoting Female Health In Africa The onset of puberty is a critical moment for reaching girls with health messages and information, and the stakes are particularly high in countries where the HIV/AIDS epidemic rages and where threats to female reproductive health abound. | 30 June 2011 |
| Bristol Young People To Run Sex Education Day For Their Peers, UK On Monday 4th July, a group of young people from across Bristol will run an interactive Sex Education Day for teenagers across the city. The event, which is supported by sexual health organisations Terrence Higgins Trust (THT) and 4YP Bristol (part of NHS Bristol), will look at issues ranging from peer pressure to the media's influence on body image through workshops, quizzes, and drama. | 30 June 2011 |
| Sleep / Sleep Disorders / Insomnia News | |
| Wake Forest Baptist Conducts Clinical Study For Insomnia Using New Technology Insomnia is the most prevalent sleep disorder, affecting up to 50 percent of the adult population in the United States on a weekly basis. Wake Forest Baptist Medical Center is conducting the first ever, randomized, controlled clinical research study in the country using Brainwave Optimization™ to treat people with insomnia. | 30 June 2011 |
| Smoking / Quit Smoking News | |
| New Anti-Smoking Text Technology Doubles Quit Chances Study Says Text to stop smoking. Period. A new study has found that smokers in the United Kingdom who receive electronic text messages to their mobile devices, doubles their chances of finally kicking the habit. | 30 June 2011 |
| Text Message Support For Smokers Doubles Quit Rates Mobile phones could hold the key to people giving up smoking after a programme involving sending motivational and supportive text messages to smokers doubled quit rates at six months.The findings of the txt2stop trial, which was led by the London School of Hygiene & Tropical Medicine and funded by the Medical Research Council, are published in The Lancet today. | 30 June 2011 |
| Sports Medicine / Fitness News | |
| Sports Scientists At The TU Muenchen Compare Men's And Women's Football Interruptions are frequent in football: Football players (m/f) spend on average 38 percent of the total game time not chasing the ball. This was established by sports scientists from the Chair of Training Science and Sports Informatics at TUM in a study of 56 football games. | 30 June 2011 |
| Stem Cell Research News | |
| A Novel Airway Stem Cell Discovered By Scientists At The Broad Stem Cell Research Center At UCLA A new type of pulmonary stem cell has been identified by scientists at UCLA. These cells have a potential to regenerate large damaged airways and play an important role in strengthening immunity against infectious agents and environmental toxins. | 30 June 2011 |
| The Promise Of Stem Cell-Based Gene Therapy Will Depend On Novel Gene Delivery Tools Sophisticated genetic tools and techniques for achieving targeted gene delivery and high gene expression levels in bone marrow will drive the successful application of gene therapy to treat a broad range of diseases. | 30 June 2011 |
| Stem Cell Breakthrough Shows Multi Regen Of Nervous System Neurons Stem cell research seems like it is not going anywhere fast. In fact breakthroughs are being announced more and more frequently. This week a Johns Hopkins team has discovered in young adult mice that a lone brain stem cell is capable not only of replacing itself and generating specialized neurons and glia (important types of brain cells), but also of taking a wholly unexpected path: generating two new brain stem cells. | 30 June 2011 |
| 3 Programs To Advance Health Research And Development The Life Sciences Discovery Fund (LSDF) has announced awards to three multi-institutional teams to support development of improved therapies and key resources for medical researchers and health-care policymakers. | 30 June 2011 |
| Transplants / Organ Donations News | |
| Heart Transplant Patients At Risk For Serious Skin Cancers A new study published in the American Journal of Transplantation reveals that there is a significant risk of serious skin cancers, including cutaneous squamous cell carcinoma and melanoma, in heart transplant patients. | 30 June 2011 |
| Texas Children's Hospital Is First Pediatric Hospital In The Nation To Implant Artificial Heart Texas Children's Hospital in Houston announced that it is the first pediatric hospital in the United States to implant an artificial heart into the chest of a 17-year-old patient as the only option to save his life. | 30 June 2011 |
| Tropical Diseases News | |
| The Fight Against Infectious Disease Aided By New Salmonella-Based 'Clean Vaccines' A powerful new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds great potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS and pneumonia. | 30 June 2011 |
| Urology / Nephrology News | |
| New Study Reveals That Muscle Invasive Bladder Cancer Cells Can Become More Susceptible To Chemotherapy Sensitized muscle invasive bladder cancer cells can be eliminated by the lethal effects of chemotherapy. This has been discovered in research conducted at the UC Davis Cancer Center that was published on June 28 in the International Journal of Cancer. | 30 June 2011 |
| Threshold Pharmaceuticals Initiates Clinical Trial Evaluating TH-302 In Combination With Sunitinib Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced the initiation of a Phase 1/2 dose escalation clinical trial of TH-302 in combination with sunitinib in patients with advanced renal cell carcinoma (RCC), gastrointestinal stromal tumor (GIST) and pancreatic neuroendocrine tumor (PNET). | 30 June 2011 |
| Fresenius Medical Care Offers Dialysis Patients Tips On How To Quench Thirst During Hot Summer Months In the heat of the summer, most people make a point to drink more to stay hydrated. But for dialysis patients, too much fluid can be life-threatening. Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, reminds patients to closely monitor their fluid intake, and offers tips on how to quench their thirst without jeopardizing their health during the hot summer months. | 30 June 2011 |
| Improving Efficacy Of Drugs For Bladder Cancer Would Boost Post-Surgery Survivorship Researchers at the UC Davis Cancer Center have discovered a way of sensitizing muscle-invasive bladder cancer cells so that they succumb to the toxic effects of chemotherapy. The finding adds to mounting evidence that tiny strands of RNA - called microRNA - play key roles in some of the deadliest types of cancer. | 30 June 2011 |
| Delayed Recognition Of Tuberous Sclerosis Complex In Adult Women Has Life-Threatening Consequences Women with tuberous sclerosis complex (TSC) are often misdiagnosed because the condition, commonly recognized in early childhood when it presents with seizures, manifests differently later in life, typically with renal angiomyolipomas a benign tumor of the kidney and pulmonary lymphangioleiomyomatosis (LAM) a rare lung disease that affects almost exclusively women. | 30 June 2011 |
| Urinary Tract Infections Reduced In Rehab Patients By Interdisciplinary Team Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings. | 30 June 2011 |
| Vascular News | |
| Boston Scientific Announces U.S. And European Launch Of Interlock™ - 35 Fibered IDC™ Occlusion System Boston Scientific Corporation (NYSE: BSX) today announced the immediate U.S. and European launch of its Interlock™ - 35 Fibered IDC™ Occlusion System. Earlier this year, the system received clearance from the U. | 30 June 2011 |
| Veterans / Ex-Servicemen News | |
| Saving Veterans From Suicide An estimated 18 American military veterans take their own lives every day - thousands each year - and those numbers are steadily increasing. Even after weathering the stresses of military life and the terrors of combat, these soldiers find themselves overwhelmed by the transition back into civilian life. | 30 June 2011 |
| Veterinary News | |
| Taking Your Pet Abroad: New Rules To Come Into Force In 2012 Defra has announced that new rules on pet travel will be introduced from 1st January 2012. The changes will mean that the rules on rabies vaccination for entry into the UK will be in line with the rest of Europe. | 30 June 2011 |
| Water - Air Quality / Agriculture News | |
| Inovio Pharmaceuticals' DNA Vaccine For Foot-And-Mouth Disease Generates Protective Neutralizing Antibodies In Second Large-Animal Study Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has achieved compelling immune responses in a study of its multi-subtype DNA vaccine for foot-and-mouth (FMD) disease administered by Inovio's proprietary vaccine delivery technology in sheep, the second large animal in which this vaccine was evaluated. | 30 June 2011 |
| Tiny Generator Powers Wireless Device Imagine a new genre of tiny implantable sensors, airborne and stationary surveillance cameras and sensors and other devices that operate without batteries on energy collected from the motion of a heart beat and have wireless communications capability. | 30 June 2011 |
| Plans To Replace Most Polluting Trucks In The Mid-Atlantic States Four Mid-Atlantic States are teaming up to offer one of the nation's most generous programs aimed at replacing old, highly polluting trucks.Led by the University of Maryland and the Mid-Atlantic Regional Air Management Association (MARAMA), the new program will target the so-called short-haul "drayage" fleet that shuttles between their major ports, warehouses and local stores. | 30 June 2011 |
| Women's Health / Gynecology News | |
| Eat Today, Pay Tomorrow - Lean Women Think Ahead Study reveals possible gender-specific influence of overeating on the brain.Being overweight is accompanied by changes in brain structure and behaviour. Researchers at the Max Planck Institute for Human Cognitive and Brain Sciences and the Integrated Research and Treatment Center Adiposity Diseases in Leipzig have shown that there are also differences between men and women. | 30 June 2011 |
| Development Of Polycystic Ovary Syndrome May Be Prevented Or Delayed By Diabetes Drug A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) found that early, prolonged treatment with the diabetes drug metformin may prevent or delay the development of polycystic ovary syndrome (PCOS) in adolescence. | 30 June 2011 |
| A Role For Glia In The Progression Of Rett Syndrome A paper published online in Nature reveals that glia play a key role in preventing the progression of the most prominent Rett Syndrome symptoms displayed by mouse models of the disease: lethality, irregular breathing and apneas, hypoactivity and decreased dendritic complexity. | 30 June 2011 |
| Reaching Girls Before They Become Sexually Active: An International Model For Promoting Female Health In Africa The onset of puberty is a critical moment for reaching girls with health messages and information, and the stakes are particularly high in countries where the HIV/AIDS epidemic rages and where threats to female reproductive health abound. | 30 June 2011 |
| You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Langganan:
Postingan (Atom)